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ABSTRACT
Between January 2005 and January 2006, 25
(12.8%) of 195 Staphylococcus aureus isolates were
positive for Panton–Valentine leukocidin (PVL)
genes in a teaching hospital in Wenzhou, China.
Nineteen (11.9%) of 160 hospital-acquired iso-
lates, and six (17.1%) of 35 community-acquired
isolates, harboured lukS ⁄ F-PV. Six sequence types
(ST88, ST239, ST398, ST25, ST30 and ST59) were
found among 18 PVL-positive methicillin-resis-
tant isolates with SCCmec types I, III, IIIA or IV.
Only ST88 was found among seven PVL-positive
methicillin-susceptible S. aureus isolates. The
PVL-positive isolates were associated with lung
infection, bloodstream infection and soft-tissue
pyogenic infection. Overall, there was a high
prevalence of PVL genes in genetically diverse
S. aureus isolates.
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Staphylococcus aureus, particularly methicillin-
resistant S. aureus (MRSA), is an important human
pathogen that causes both hospital- and commu-
nity-acquired infections worldwide [1–3]. The
resistance of MRSA to b-lactam antibiotics is
associated with penicillin-binding protein 2a,
encoded by the mecA gene. This gene is located
on a mobile element, the staphylococcal cassette
chromosome mec (SCCmec), with at least ﬁve
different types of SCCmec having been reported
[4,5]. Hospital-acquired MRSA (HA-MRSA) iso-
lates harbour mainly SCCmec types I, II and III,
whereas SCCmec types IV and V are found mainly
in community-acquired MRSA (CA-MRSA) iso-
lates [4,5]. In addition, CA-MRSA isolates often
produce Panton–Valentine leukocidin (PVL),
encoded by two co-transcribed genes, lukS-PV
and lukF-PV (lukS ⁄F-PV) [1–6]. S. aureus isolates
producing PVL have been associated predomi-
nantly with severe skin infections and necrotising
pneumonia [6–9]. The prevalence of PVL genes
among clinical isolates of S. aureus in China is not
known. The aim of the present study was to
investigate the prevalence of the PVL genes and
the molecular characteristics of S. aureus isolates
from hospitalised patients in a teaching hospital in
China.
The First Afﬁliated Hospital of Wenzhou Med-
ical College (1500 beds) is the largest hospital in
Wenzhou, China. Approximately 35 000 patients
were admitted to the hospital between January
2005 and January 2006. Isolates of S. aureus were
obtained from the clinical specimens of hospita-
lised patients. Isolates were conﬁrmed as S. aureus
using a Staph SPA agglutination kit (bioMe´rieux,
Marcy l’Etoile, France), Gram’s stain and a
Vitek-60 microbiology analyser (bioMe´rieux).
The reference strains used were S. aureus
ATCC 25923, MRSA NCTC 10442 (SCCmecI),
MRSA N315 (SCCmecII), MRSA 85 ⁄ 2082 (SCCme-
cIII) and MRSA JCSC4744 (SCCmecIV). The
antimicrobial susceptibility of isolates was deter-
mined by disk-diffusion according to CLSI
recommendations [10]. The presence of the mecA
and lukS ⁄F-PV genes was determined as
described previously [11]. SCCmec typing [12]
and multilocus sequence typing [13] were also
performed as described previously. Isolates
recovered in £72 h following hospitalisation,
combined with other criteria [14,15], were
considered to be community-acquired.
The sources and numbers of clinical specimens
examined are listed in Table 1. In total, of 195 S
aureus isolates, 25 (12.8%) were positive for PVL
(Table 1). The positivity rates of lukS ⁄ F-PV in
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isolates from abscesses, wounds and blood were
higher than those in isolates from other clinical
specimens. The molecular characteristics and
antimicrobial resistance proﬁles of the PVL-
positive isolates are summarised in Table 2.
The 19 PVL-positive hospital-acquired S. aureus
isolates were associated mainly with lung infec-
tion and pyogenic post-operative wound surface
infections in middle-aged and elderly patients
with cerebral disease from different wards. Six
PVL-positive community-acquired S. aureus
isolates were associated mainly with pyogenic
soft-tissue infection in younger patients. The
PVL-positive isolates were from 14 ward areas,
but were mainly from the neonatal and obstetrical
departments, as well as the intensive care unit.
In total, six sequence types (STs) were found
among the 25 PVL-positive isolates. ST88 was the
clone detected most often in this study, and this
clone caused pyogenic soft-tissue infection in ten
patients, and bloodstream infection in two
patients. Other MRSA STs caused mainly lung
and urinary tract infection. ST88 PVL-positive
SCCmecIIIA MRSA isolates were obtained from
abscesses or blood of three infants with soft-tissue
infection in the neonatal department, following
transfer from the obstetrical department. Another
ST88 PVL-positive SCCmecIII MRSA isolate was
obtained from a pyogenic canthus secretion from a
pregnant woman. These four isolates had very
similar molecular characteristics and antimicrobial
resistance proﬁles, and may therefore have
Table 2. Characteristics of Panton–Valentine leukocidin-positive isolates of Staphylococcus aureus
Patient
age Specimen Ward
Sequence
type (ST) mecA
SCCmec
type
Antimicrobial susceptibility
HA or
CAP E G T S L
40 years Sputum Emergency ICU 25 + III R R R R R R HA
20 years Abscess Ear, nose and throat 30 + IV R R S S S S CA
44 years Sputum Emergency ICU 59 + I R R S R S S HA
10 daysa Blood Neonatal 88 + IIIA R S S S R S HA
14 days Abscess Neonatal 88 + IIIA R S S S R S HA
8 days Abscess Neonatal 88 + IIIA R S S S R S HA
28 years Abscess Obstetrics 88 + III R R S S R S HA
59 years Abscess Transplant 88 ) R S S S S S HA
24 years Abscess Obstetrics 88 ) R R R S R S CA
31 years Abscess General surgery 88 ) R S S S R S CA
26 years Abscess General surgery 88 ) R R S S S S CA
67 years Blood Cardiac 88 ) S R S S S S CA
40 years Sputum ICU 88 + III R S S S R S HA
40 years Blood ICU 88 ) R S S S R S HA
35 years Abscess Renal 88 ) R R S S S S HA
75 years Sputum Haematology 239 + III R R R R S R HA
79 years Sputum Neurology 239 + III R R R R S R HA
43 years Urine Neurology 239 + III R R R S R S HA
82 years Sputum ICU 239 + III R R R R S R HA
86 years Urine Cardiac 239 + III R R R R R R HA
58 years Sputum ICU 398 + III R R R R S R HA
67 years Sputum Respiratory 398 + IV R R R S R S HA
47 years Sputum Transplant 398 + IV R R S S R S HA
48 years Sputum Neurosurgery 398 + III R R R R S R HA
3 years Abscess Empyema surgery 398 + IV R R R S S S CA
R, resistant; S, susceptible; P, penicillin; E, erythromycin; G, gentamicin; T, tetracyline; S, trimethoprim–sulphamethoxazole; L, levoﬂoxacin; ICU, intensive care unit; HA,
hospital-acquired; CA, community-acquired.
aThe same organism was isolated from an abscess 4 days later.
Table 1. Prevalence of Panton–Valentine leukocidin (PVL) genes among isolates of Staphylococcus aureus from patients in
Wenzhou Hospital, China
S. aureus
isolates
Source of isolates
Hospital-acquired
(HA) or community-
acquired (CA)
infection
Methicillin
susceptibility
Sputum
(n = 7365)
Abscess or
wound
(n = 280)
Blood
(n = 3492)
Urine
(n = 2213)
Others
(n = 1025)
Total
(n = 14 375) HA CA MRSA MSSA
Total 147 25 7 8 8 195 160 35 121 74
PVL-positive (%) 10 (6.8) 10 (40) 3 (42.9) 2 (25) 1 (12.5) 25 (12.8) 19 (11.9) 6 (17.1) 18 (14.9) 7 (12.2)
MRSA, methicillin-resistant S. aureus; MSSA, methicillin-susceptible S. aureus.
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belonged to the same clone, with the three infants
possibly acquiring infection from the pregnant
woman in the obstetrical department. Soft-tissue
infection in three patients and septicaemia in one
patient were caused by ST88 PVL-positive com-
munity-acquired methicillin-susceptible S. aureus
(CA-MSSA). Five ST398 PVL-positive MRSA iso-
lates resistant to multiple antibiotics were associ-
ated with lung and wound infections in elderly
patients. All patients with pyogenic infections
recovered andwere discharged following incision,
drainage and antibiotic treatment.
In contrast to the present study, some previous
reports have described a low prevalence of PVL
genes in S. aureus (<5%), and a particularly low
prevalence in HA-MRSA [11,16]. However, in
Taiwan, the prevalence of PVL-positive MRSA
isolates in hospitals during 2005 was 23.3% [1].
The ST239 MRSA clone that spread in Saudi
Arabia and Romania during 2005 caused mainly
hospital infections [17]. The present study
revealed ﬁve ST239 SCCmecIII PVL-positive
HA-MRSA isolates, and these isolates were
multiresistant to antibiotics. ST239 SCCmecIII
MRSA is possibly the most successful inter-
national epidemic clone of HA-MRSA worldwide.
Only one ST30 CA-MRSA isolate was detected in
the present study, but ST30 MRSA has been
reported previously to be the most important
clone associated with community-acquired infec-
tion in Singapore during 2006 [18]. In Belgium,
ST88 SCCmecIV MRSA caused community-
acquired infection [19], whereas the present study
revealed that four ST88 isolates associated with
community-acquired infection were all MSSA.
Although ST88 MSSA isolates were generally
susceptible to antibiotics, the infections caused
by these isolates should not be overlooked,
because of their high pathogenicity. In the present
study, two inpatients with typical hospital-
acquired infection were infected by ST398
SCCmecIV MRSA isolates with molecular charac-
teristics of CA-MRSA (PVL-positive and
SCCmecIV). Two isolates with characteristics
typical of CA-MRSA were isolated from hospita-
lised patients, and it seems that PVL-positive
CA-MRSA and CA-MSSA isolates have spread to
the hospital. MRSA strains with the molecular
characteristics of CA-MRSA strains have emerged
as an important cause of serious healthcare-
associated infection [20]. Overall, the present
study of S. aureus isolates from hospitalised
patients in Wenzhou, China revealed a diversity
of genetic backgrounds and a high prevalence of
PVL-encoding genes.
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ABSTRACT
The capacity of Staphylococcus aureus strain
LUG855 to release Panton–Valentine leukocidin
(PVL) in the presence of sub-inhibitory concen-
trations of anti-staphylococcal drugs was exam-
ined. Oxacillin enhanced PVL release 2.5-fold,
while clindamycin, linezolid, fusidic acid and
rifampicin were inhibitory, and vancomycin,
pristinamycin, tetracycline, oﬂoxacin and co-
trimoxazole had no effect. In combination with
oxacillin, sub-inhibitory concentrations of clinda-
mycin or rifampicin inhibited PVL induction
signiﬁcantly, linezolid was less inhibitory, and
fusidic acid did not inhibit PVL induction by
oxacillin. These data support the use of oxacillin
in combination with clindamycin, rifampicin or
linezolid for the treatment of PVL-positive
S. aureus infections.
Keywords Clindamycin, fusidic acid, linezolid, oxa-
cillin, Panton–Valentine leukocidin, rifampicin, Staphy-
lococcus aureus
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